187 related articles for article (PubMed ID: 19485574)
21. Anatomical phenotyping in a mouse model of fragile X syndrome with magnetic resonance imaging.
Ellegood J; Pacey LK; Hampson DR; Lerch JP; Henkelman RM
Neuroimage; 2010 Nov; 53(3):1023-9. PubMed ID: 20304074
[TBL] [Abstract][Full Text] [Related]
22. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
Koekkoek SK; Yamaguchi K; Milojkovic BA; Dortland BR; Ruigrok TJ; Maex R; De Graaf W; Smit AE; VanderWerf F; Bakker CE; Willemsen R; Ikeda T; Kakizawa S; Onodera K; Nelson DL; Mientjes E; Joosten M; De Schutter E; Oostra BA; Ito M; De Zeeuw CI
Neuron; 2005 Aug; 47(3):339-52. PubMed ID: 16055059
[TBL] [Abstract][Full Text] [Related]
23. Control of hormonal stress reactivity by the endogenous opioid system.
Bilkei-Gorzo A; Racz I; Michel K; Mauer D; Zimmer A; Klingmüller D; Zimmer A
Psychoneuroendocrinology; 2008 May; 33(4):425-36. PubMed ID: 18280051
[TBL] [Abstract][Full Text] [Related]
24. Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.
Shang Y; Wang H; Mercaldo V; Li X; Chen T; Zhuo M
J Neurochem; 2009 Nov; 111(3):635-46. PubMed ID: 19659572
[TBL] [Abstract][Full Text] [Related]
25. Fmrp is required for the establishment of the startle response during the critical period of auditory development.
Yun SW; Platholi J; Flaherty MS; Fu W; Kottmann AH; Toth M
Brain Res; 2006 Sep; 1110(1):159-65. PubMed ID: 16887106
[TBL] [Abstract][Full Text] [Related]
26. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects of chronic stress in the Fmr1 mouse model for fragile X syndrome.
Lemaire-Mayo V; Subashi E; Henkous N; Beracochea D; Pietropaolo S
Behav Brain Res; 2017 Mar; 320():128-135. PubMed ID: 27939692
[TBL] [Abstract][Full Text] [Related]
28. Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.
Paylor R; Yuva-Paylor LA; Nelson DL; Spencer CM
Behav Neurosci; 2008 Dec; 122(6):1371-7. PubMed ID: 19045956
[TBL] [Abstract][Full Text] [Related]
29. Effects of chronic footshock, restraint and corticotropin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats.
Swiergiel AH; Zhou Y; Dunn AJ
Behav Brain Res; 2007 Nov; 183(2):178-87. PubMed ID: 17645963
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines.
Grossman AW; Elisseou NM; McKinney BC; Greenough WT
Brain Res; 2006 Apr; 1084(1):158-64. PubMed ID: 16574084
[TBL] [Abstract][Full Text] [Related]
31. Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome.
Moon J; Beaudin AE; Verosky S; Driscoll LL; Weiskopf M; Levitsky DA; Crnic LS; Strupp BJ
Behav Neurosci; 2006 Dec; 120(6):1367-79. PubMed ID: 17201482
[TBL] [Abstract][Full Text] [Related]
32. Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are specific to the ventral dentate gyrus.
Eadie BD; Zhang WN; Boehme F; Gil-Mohapel J; Kainer L; Simpson JM; Christie BR
Neurobiol Dis; 2009 Nov; 36(2):361-73. PubMed ID: 19666116
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of effects of previous exposure to an acute stressor before testing for depression-like behaviours in mice.
Chourbaji S; Brandwein C; Vogt MA; Dormann C; Gass P
Stress; 2008 Mar; 11(2):170-5. PubMed ID: 18311605
[TBL] [Abstract][Full Text] [Related]
34. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.
Pacey LK; Heximer SP; Hampson DR
Mol Pharmacol; 2009 Jul; 76(1):18-24. PubMed ID: 19351745
[TBL] [Abstract][Full Text] [Related]
35. Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.
de Diego-Otero Y; Romero-Zerbo Y; el Bekay R; Decara J; Sanchez L; Rodriguez-de Fonseca F; del Arco-Herrera I
Neuropsychopharmacology; 2009 Mar; 34(4):1011-26. PubMed ID: 18843266
[TBL] [Abstract][Full Text] [Related]
36. AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice.
Mead AN; Morris HV; Dixon CI; Rulten SL; Mayne LV; Zamanillo D; Stephens DN
Behav Neurosci; 2006 Apr; 120(2):241-8. PubMed ID: 16719688
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model.
Gantois I; Vandesompele J; Speleman F; Reyniers E; D'Hooge R; Severijnen LA; Willemsen R; Tassone F; Kooy RF
Neurobiol Dis; 2006 Feb; 21(2):346-57. PubMed ID: 16199166
[TBL] [Abstract][Full Text] [Related]
38. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.
Nielsen DM; Derber WJ; McClellan DA; Crnic LS
Brain Res; 2002 Feb; 927(1):8-17. PubMed ID: 11814427
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.
Heulens I; D'Hulst C; Van Dam D; De Deyn PP; Kooy RF
Behav Brain Res; 2012 Apr; 229(1):244-9. PubMed ID: 22285772
[TBL] [Abstract][Full Text] [Related]
40. Altered auditory processing in a mouse model of fragile X syndrome.
Rotschafer S; Razak K
Brain Res; 2013 Apr; 1506():12-24. PubMed ID: 23458504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
